Partner Content Partner Content 6th Annual 3D Cell Culture Conference www.3d-cellculture.com/PharmaphorumWL
News Novartis' oral BTK drug moves the needle in CINDU Novartis is set to expand the label for its oral BTK inhibitor Rhapsido, keeping the drug on course to become one of its biggest-ever brands.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
